Accreditation Sets New Standards for Clinical AI Governance
DirectTrust, a nonprofit healthcare industry alliance, has launched its Artificial Intelligence v1.0 Accreditation Program, establishing structured requirements for organizations developing or deploying AI in healthcare. The program emphasizes governance, transparency, risk management, performance evaluation, and ongoing oversight. Three organizations achieved accreditation during the beta phase: D.A.W. Systems and ZeOmega earned Foundational accreditation, while Inpriva became a Candidate for Comprehensive accreditation. The final criteria are now publicly available, giving healthcare organizations a clear framework for ensuring AI tools meet safety and reliability standards before reaching clinical settings. For hospital CISOs and compliance officers, this program provides a benchmark for evaluating whether AI vendors have adequate governance structures in place to protect patient safety and data integrity.
Implications for Hospital Security and Clinical Operations
The accreditation program addresses a critical gap in healthcare AI oversight. As health systems increasingly deploy AI for clinical decision support, imaging analysis, and administrative workflows, the need for standardized evaluation has become urgent. The DirectTrust framework requires organizations to demonstrate robust risk management and ongoing monitoring capabilities, which directly supports HIPAA compliance and patient safety goals. Hospital security teams can use this accreditation as a due diligence tool when evaluating AI vendors, similar to how they assess EHR security certifications. The program also aligns with FDA’s evolving approach to AI/ML-enabled medical devices, giving health systems a consistent way to evaluate both regulated and non-regulated AI tools.
What This Means for Healthcare Organizations
Healthcare leaders should immediately review the DirectTrust AI accreditation criteria and consider whether their current and prospective AI vendors meet these standards. The accreditation covers governance structures that are essential for managing clinical AI risks, including transparency around training data, performance evaluation in real-world settings, and mechanisms for reporting and addressing errors. For hospitals and health systems, adopting these criteria as vendor requirements can help prevent the integration of AI tools that might introduce patient safety risks or compliance gaps. The accreditation program also supports the work of hospital AI governance committees, which are increasingly responsible for approving AI tools before they reach clinicians and patients.
Source: Healthitanswers
